ALT

Altimmune Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 5/10
  • Momentum↓ 3/10
Altimmune sales and earnings growth
ALT Growth
Neutral
  • Revenue Y/Y↓ -68.09%
  • EPS Y/Y↑ 31.85%
  • FCF Y/Y↑ 15.05%
Altimmune gross and profit margin trends
ALT Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -559433.30%
  • ROIC↓ -92.80%
Altimmune net debt vs free cash flow
ALT Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -110.2

Altimmune stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗